Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
WHIF (Women’s Health Impact Fund) is a €50 million venture capital fund founded in Greece, dedicated to advancing women’s health innovations across Europe. Established to address the unique health challenges faced by women, WHIF focuses on driving measurable outcomes through investments in innovative and scalable solutions. The fund aims to significantly improve women's health by supporting high-growth verticals that can expand internationally.
Currently, WHIF operates across Europe and is positioned to scale globally. The fund's commitment to women's health is reflected in its targeted investment strategy, which emphasizes sectors that directly impact women's well-being. WHIF seeks to create a lasting impact by funding companies that prioritize women's health innovations.
WHIF invests in high-growth verticals within women’s health, specifically targeting scalable platforms that are positioned for international expansion. The fund's key focus areas include reproductive health, menopause and midlife health, maternal health, digital therapeutics and AI, women's oncology, mental health and neuroendocrine solutions, and longevity and healthy aging.
In reproductive health, WHIF looks for innovations in fertility technologies and reproductive diagnostics. For menopause and midlife health, the fund seeks hormonal health platforms and metabolic solutions. Maternal health investments include pregnancy monitoring and postnatal care innovations. Digital therapeutics and AI are also critical, with a focus on data-driven clinical platforms and precision health systems. Additionally, WHIF is interested in gender-specific diagnostics and therapeutic innovations in women's oncology, as well as solutions for mental health and neuroendocrine issues.
Founders interested in pitching to WHIF should send their proposals via email to areti@whif.eu. It is important to include a comprehensive overview of the startup, its mission, and how it aligns with WHIF's investment focus. Response times may vary, so founders should be prepared for potential follow-up discussions.
What are WHIF's investment criteria?
WHIF focuses on investing in scalable solutions that significantly improve women's health outcomes. The fund targets high-growth verticals within women’s health, including reproductive health, maternal health, and digital therapeutics.
How can founders apply or pitch to WHIF?
Founders can pitch WHIF by sending an email to areti@whif.eu. It is advisable to include a detailed overview of the startup, its mission, and how it aligns with WHIF's focus areas.
What makes WHIF different from other venture capital firms?
WHIF is uniquely dedicated to advancing women’s health innovations, focusing specifically on sectors that impact women's health. This specialized approach allows WHIF to provide targeted support and resources to portfolio companies.
What is WHIF's geographic scope?
WHIF operates primarily across Europe but is also positioned to scale globally. The fund seeks to invest in companies that have the potential for international expansion.
What is the typical check size for investments?
WHIF's fund size is €50 million, and while specific check sizes are not disclosed, the fund typically invests in seed to Series B stages, indicating a range that aligns with early to growth-stage companies.
What kind of post-investment involvement does WHIF have?
WHIF is committed to driving measurable outcomes for its portfolio companies, which may include providing operational support and strategic guidance to help them scale effectively.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.